s10029-012-1037-8

EDAR Antibody (RM0077-8L53) Summary

    Immunogen
    Mouse recombinant EC-domain of EDAR
    Specificity
    This was produced from a hybridoma (mouse myeloma fused with spleen cells from a rat immunized with mouse recombinant Extracellular Domain of EDAR.
    Isotype
    IgG2
    Clonality
    Monoclonal
    Host
    Rat
    Gene
    EDAR
    Purity
    Protein G purified
    Innovators Reward
    Test in a species/application not listed above to receive a full credit towards a future purchase.

    Learn about the Innovators Reward

Applications/Dilutions

    Dilutions
        Western Blot 1:500-1:1000
    Application Notes
    This antibody detects mouse EDRA in Western blotting and cross reacts with human EDAR.

Reactivity Notes

Mouse.

Packaging, Storage & Formulations

    Storage
    Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
    Buffer
    A 0.2 um filtered solution in PBS
    Preservative
    No Preservative
    Concentration
    LYOPH
    Purity
    Protein G purified
    Reconstitution Instructions
    Reconstitute with 0.2 ml sterilized PBS to a final concentration of 0.5 mg/ml.

Alternate Names for EDAR Antibody (RM0077-8L53)

      Anhidrotic ectodysplasin receptor 1
      DLED3
      Ectodermal dysplasia receptor
      ectodysplasin 1, anhidrotic receptor
      ectodysplasin A receptor
      Ectodysplasin-A receptor
      ED1R
      ED5
      EDA1R
      EDA3EDA-A1 receptor
      EDA-A1R
      EDAR
      FLJ94390
      HRM1
      mouse, homolog of
      tumor necrosis factor receptor superfamily member EDAR

Background

EDAR (Ectodysplasin A receptor) is a receptor for EDA isoform A1, but not for EDA isoform A2. It has a single transmembrane domain, and shows similarity to 2 separate domains of the tumor necrosis factor (TNF) receptor (TNFR) family. It mediates the activation of NF-kappa-B and JNK and may promote caspase independent cell death. Defects in EDAR are a cause of hypohidrotic ectodermal dysplasia.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Gilteritinib

Related Post